LIFT-TB Philippines

BPaL Reference Materials

Download reference materials

Latest LIFT-TB News

LIFT-TB PHIL HOLDS A SYMPOSIUM TO COMMEMORATE WORLD TB DAY AND SUPPORT PROGRAMMATIC SCALEUP OF THE NEW DR-TB REGIMEN

NEW PEERLINC KNOWLEDGE HUB WILL LEVERAGE LOCAL EXPERTISE AND EXPERIENCE TO ACCELERATE NEW, MORE EFFECTIVE TB CURES AROUND THE WORLD (article from tballiance.org/news)

OR SITES RECOGNIZED FOR THEIR CONTRIBUTION TO BPAL OPERATIONAL RESEARCH

ACTIVE TB DRUG SAFETY AND MONITORING (ADSM) WORKSHOP: STRENGTHENING ADSM MANAGEMENT IN DRUG-RESISTANT TB

Patient-Centered TB Regimens Highlighted During 2023 PHILCAT Convention

Papua New Guinea Delegates Focus on BPAL Operational Research Experience in the Philippines

Papua New Guinea Study Tour on Drug-Resistant TB Management in the Philippines

Treatment regimens for drug resistant TB will see a price drop up to 29%

LIFT-TB PHILIPPINES PROJECT COMMENCES JOINT MONITORING WITH THE BPAL RESEARCH TEAM

TB PARTNERS CELEBRATE THE JOURNEY FROM LONG TO SHORTER TREATMENT DURING WORLD TB DAY 2023

STORIES OF HEALING: BPAL BRINGS HOPE FOR DRUG-RESISTANT TB PATIENTS

BPAL RESEARCH IMPLEMENTATION REVIEW HELPS PAVE THE WAY TOWARDS A SMOOTH TRANSITION TO PROGRAMMATIC BPAL IMPLEMENTATION

TEAMWORK MAKES THE DREAM WORK: THE DRIVING FORCE BEHIND BPAL OR’S SUCCESS

TB ALLIANCE COMMITS SUPPORT FOR THE PROGRAMMATIC SCALE UP OF WHO-RECOMMENDED REGIMENS FOR MDR/RR-TB IN THE PHILIPPINES

Milestone reached in LIFT-TB Philippines

WHO updates Guidelines on the treatment of Drug-resistant Tuberculosis

LIFT-TB PHILIPPINES SHARES CLINICAL EXPERIENCE IN BPAL OPERATIONAL RESEARCH IN THE 53rd UNION WORLD CONFERENCE ON LUNG HEALTH

New Study: Recently Approved Drug-Resistant TB Treatments Can Save National Governments up to US$740 Million Annually

ITRC Korea Experts Conduct Laboratory Training for LIFT-TB BPaL Operational Research in the Philippines

FDA APPROVES PRETOMANID REGISTRATION IN THE PHILIPPINES

TB Alliance Statement on New World Health Organization Rapid Communication on Key Changes to the Treatment of Drug-Resistant Tuberculosis — TB Alliance

LIFT-TB Philippines conducts first on-site training for REDCap

NTP-Philippines Implements XPERT MTB/XDR for Rapid Detection of Fluoroquinolone Resistance

Increasing the Effectiveness of the Diagnosis and Management of Difficult-to-treat BPAL or Cases Through the Tb Medical Advisory Committee (TBMAC)

Frontline Healthcare Providers in the Philippines Assert the High Acceptability of the BPAL Regimen

Questions and Answers from the BPaL OR Project Implementation Review- Philippines

BPaL OR holds its first Project Implementation Review

First patient graduates from the six-month all-oral BPaL regimen

Update on Pretomanid,in Combination with Bedaquiline and Linezolid (the BPaLRegimen) in Drug-Resistant TB

TB Alliance Welcomes New Data on BPaL-Based Regimens Presented at the 2021 Union Conference

The BPaL regimen offers hope to more drug-resistant TB patients in the Philippines

Strengthening the BPaL OR’s laboratory component through laboratory needs assessment

The Philippines enrols first patient with highly drug-resistant TB on the BPaL regimen (Acknowledgment: Dr. Irene Flores)

Research Team Spearheads the Implementation of the BPaL Operational Research in the Philippines

TDF LIFT-TB Philippines Project gears for BPaL OR implementation with needs assessment of OR sites

The Department of Health announces full support through a Department Memorandum endorsing the conduct of preparatory activities of the BPaL OR

The BPaL regimen offers a beacon of hope for MDR-TB and XDR-TB patients

LIFT-TB Philippines, Launch Programme

LIFT-TB Philippines launched to commence the operational research using the BPaL regimen

Subscribe to our newsletter

Sign up for our occasional newsletter and get news and updates from Lift-TB Philippines.